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tive risk models were built using risk scores based on regression ~ values. Cox regres- 
sion entering only traditional factors showed that age (risk scores: <60 years = 0, 60-64 
years = 1, 65-69 years = 2, 70-79 years = 5, ->80 years = 8), diabetes (yes = 1), congas- 
tive heart failure (yes = 2), LV ejection fraction (_>65% = 0, 41-64% = 1, _<40% = 4), num- 
ber of severe coronaries (1 = 0, 2-3 = 1), and treatment type (ravasculadzation = 0, 
medical treatment = 1) predicted mortality (ROC area: 0.733 for the risk factor sum, 
0.747 for categorical variables). CRP (<1.0 mg/dL = 0, 1.0-1.99 mg/dL = 2, 2.0-4.99 mg/ 
dL = 4, ->5.0 mg/dL = 5), CMV (seroposittve = 2), and HCY (>16 pmol/L = 1) were each 
significant, independent predictors of mortality, and the full risk model including traditional 
and novel factors improved ROC areas to 0.764 (risk sum) and 0.777 (categories). 
Conch.rslone: The Intermountain Risk Model provides an excellent assessment of mor- 
tality risk for patients with existing CAD; further, addition of novel risk factors (CRP, CMV, 
HCY) increases the accuracy of the risk model. The Intermountain Risk Model may pro- 
vide an enhanced ability to evaluate risk of mortality and guide therapy in CAD patients. 
3:00 p.m. 
827-5 Economic Consequences of  Rout ine  Coronary  
Angiography in Low-Risk Pat ients  With Unstable 
Angina 
Akshav S. Desai. Daniel H. Solomon, Peter H. Stone, Christopher P. Cannon, Jerry 
Avorn, Brigham and Women's Hospital, Boston, Massachusetts. 
BACKGROUND: In low-risk patients with unstable angina and non-ST elevation myocar- 
dial infarction (U/VNSTEMI), early invasive management with coronary angiography 
does not reduce the risk of death or MI. Yet, such patients are often managed invasively. 
The economic consequences of an invasivs management strategy in low-risk patients 
are unknown. 
METHODS: A risk prediction rule was applied to a multi-hospital clinical case database 
and to the trial population of Thrombofysis in Myocardial Ischemia IIIB (TIMI tilB), which 
compared eady invasive to conservative therapy for UA/NSTEMI. The effect of the early 
invasive strategy was analyzed with regard to the composite endpoint of death, MI, or 
rehospitalizatJon (rehosp) for rest ischemia at 42 days and at 1 year using a logistic 
regression model in patients with high and low risk scores. Costs and benefits of early 
invasive management of low-risk patients were assessed using 1999 Medicare reim- 
bursement data. 
RESULTS: In our case database, 56.5% of low-risk patients with UNNSTEMI underwent 
early cardiac catheterization. In TIMI IIIB, early invasive management of Iow-dsk patients 
with unstable angina was associated with no difference in the rate of death or MI relative 
to medical therapy. However, when rehosp was added to the composite endpoint, inva- 
sive management was superior to conservative management at both 42 days (P=.005) 
and at 1 year (P=0.03) in all risk groups. Thus, 5.4% of rehospitalizations in low-risk, con- 
servatively managed patients would have been avoided had they been treated instead 
with an early invasive strategy. Within TIMI IIIB, this amounts to 40 fewer rehospitaliza- 
tions at an additional cost of $2,668,200 to $6,921,400. This expenditure of $66,700 to 
$173,000 per hospitalization prevented far exceeds the monetary cost of rehospitaliza- 
tion ($13,200). 
CONCLUSIONS: Although common in clinical practice, routine early invasive manage- 
ment of low-risk patients with unstable angina generates significant health care costs 
without mortality benefit. Unless the incremental benefit in quality of life from prevented 
hospitalizations is judged to be worth the large incremental cost, such a strategy is 
unlikely to be cost-effective. 
3:15 p.m. 
827-6 R isk -Ad jus ted  Morta l i ty  by  Extent  of  Coronary  
Ca lc i f i cat ion  
Tracv Q. Callister. Enrique F. Schisterman, Daniel Berman, Paolo Raggi, Leslea J. Shaw, 
EBT Research Foundation, Nashville, Tennessee, Tulane University, New Orleans, 
Louisiana. 
Background: Preliminary evidence in small observational datasets suggests that there is 
an association of cardiac events and coronary calcium scores (CCS). Despite this prom- 
ising evidence, few data exist using risk-adjusted multivadable models to predict death 
as the sole primary endpoint as a function of CCS. 
Methods: A cohort of 10,377 asymptomatic individuals were screened for CCS with elec- 
tron beam tomography (EBT). The prevalence of cardiac risk factors were as follows: 
family history of CAD 69%, hyperchoiesteroiemia 62%, hypertension 44%, current smok- 
ing 40%, and diabetes 9%. CCS was categorized into the following: 1000. Multivadable 
Cox proportional hazard models were developed to predict all-cause mortality. Risk- 
adjusted models incorporated all traditional risk factors for CAD, i.e. age, gender, hyper- 
tension, family history of CAD, diabetes mellitus, hypercholesterolemia, current cigarette 
smoking. Total mortality was determined by the National Death Index. During an average 
follow-up of 5.0+3.5 years, 249 deaths (2.4%) were reported, 
Results: In a risk-adjusted model CCS was an independent predictor of mortality 
(c2=36.6, p<0.00001). The incremental value of CCS (defined as % D model c2) was 
42.7% reflecting the amount of new predictive information contained within the CCS. 
Adjusted relative risks for CCS were 1.64 (p=0.01), 1.74 (p=0,008), 2.54 (p<0.00001), 
and 4.03 (pl000 respectively, with the <10 as the reference category. Figure 1. shows 
risk-adjusted survival curves: 5 year survival was 99% for those with a calcium score < 10 
but only 95% for those with a calcium score >1000. 
Conclusion: This observational cohort study reveals that CCS is an independent predic- 
tor of mortality. These findings suggest that CCS may play a role in risk stratification, 
which would help guide risk-reducing strategies for the treatment of coronary atharoscle- 
rotic disease, 
ABSTRACTS - Special Topics 447A 
.gQ, 
'i 
.94 
CCS CMegery 
ugm. >1000 
m 401-1000 
-~- -  101-4G0 
10-100 
- - - - -  <10 
200O 
POSTER SESSION 
1143 Assessment and Outcome in 
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Georgia World Congress Center, Hall G 
Presentation Hour: 4:00 p.m.-5:00 p.m. 
1143-163 Compar i son  of  Early Dobutamine Stress  
Echocardiography, Exercise Treadmill Testing, and 
Hosp l ts l  Admiss ion  fo r  Management  o f  Pat ients  
Presenting to  the  Emergency  Depar tment  With Chest  
Pain: A Multicenter International Randomized Study 
Luiai P. Badano. Nizal Sarref-Zadegan, Mare Baldassi, Giorgio Scaffidi, Apostolos 
Karavidas, Vitas Vysniauskas, Bads Uerigelan, Costantino Astarita, Gianni Pettinati, 
Alessandro Dasideri, Marco Ghidina, Dado Gregod, Paolo M. Fioretti, on behalf of the 
ASSENCE investigators, IRCAB Foundation, Udine, italy. 
Background. Management of patients presenting to emergency department (ED) with chest 
pain (CP) suggestive of acute coronary syndrome remains a continuing challenge, and 
these pts are often admitted to rule out acute myocardial infarction (AMI) and prevent sud- 
den death. To reduce unnecessary admissions, maintain pt safety, and enhance cost-effec- 
tiveness, several strategies have been applied to the management of pts with CP. However, 
efficacy and safety of these strategies have never" been compared in a randomized study. 
We conducted our study to compare safety and cost-effectiveness of dobutamine stress 
echocardiography (DSE) or exercise treadmill tasting (E'l-I') versus hospital admission. 
Methods. This was a randomized, prospective, international study of ED pts with CP over 
age 30, with no prior cardiac history, normal CK-MB and cardiac troponin, a non ischemic 
EKG at 6 hours from ED presentation and who were to be admitted. Pts were randomissd to 
immediate DSE or E'l-]', or admission. Pts with normal DSE or E'I-I" were discharged. Fol- 
low-up was at 1 weak, 1 month and 2 months. End-points were defined as AMI, sudden 
death, angina requiring admission, need for revascularization, re-hospitalization for CP, in- 
hospital length-of-stay, hospital charges. 
Results, Three hundred ten pts were enrolled in 7 participating centers, 126 in the DSE 
group, 89 in the E'I-I" group and 95 in the admitted group, There was no difference in age, 
gender, clinical charectedstics of CP, or risk factors among the 3 pt groups. There were 6 in- 
hospital events (1.9°/o): 4 AMI (3 in the admitted pt group and 1 in the DSE group), and 2 
PTCA (1 in the admitted group and I in the DSE group). Ischemic origin of CP was diag- 
nosed in 38% of the study population. Eighty-seven (69%) pts were discharged after DSE, 
and 85 (89%) were discharged after ETT (p<0.001). None of the pts discharged after DSE 
or E'l-r suffered a late event. In-hospital langth-of-stay was 26±8 hours in DSE pts, 26±4 
hours in ETT pts, and 72±11 hours in admitted patients (p<0.0001). 
Conclusions. Early DSE or ETT in ED pts with CP, normal CK-MB, troponin and EKG at 6 
hours is safe, has an equivalent predictive value for cadiac events and is lass expensive as 
compared to hospital admission 
1143-164 Impact  of  an Init ial D iagnost i c  Test  on  Subsequent  R isk  
St rat i f i cat ion fo r  Pat ients  With Mul t ip le  ED V is i ts  fo r  
Chest  Pain 
Robert L, Jesse, Steohen G. Phitiio~. Michael C. Kontos, Charlotte S. Roberts, 
Shantaram Rangappa, Joseph P. Omato, James L. Tatum, Virginia Commonwealth 
University Health System / Medical College of Virginia, Richmond, Virginia. 
BACKGROUND: Chest pain (CP) accounts for 5-8 million Emergency Department (ED) vis- 
its each year. We noted that a large proportion of CP patients (pts) had multiple visits, and 
were often triaged to a higher risk level on subsequent visits without obvious clinical indica- 
tion. This study examines whether the diagnostic modality used to exclude coronary artery 
disease (CAD) during any one visit influenced decision making during subsequent ED visits 
for these pts. 
METHODS: A retrospective analysis for mul~pie visits via a previously validated robust CP 
database, was performed on all ED CP pts from 6/94 to 7/01. Recidivism was defined as 2 
or more ED visits during any 6 month period. Pts were triaged to one of 4 risk levels in the 
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ED according to institutional protocol. Triage level assignment for each ED visit was com- 
pared relative to the diagnostic test done on the previous visit. Only patients who had CAD 
excluded across all visits were considered in this analysis 
RESULTS: Of the 19,875 ED visits for CP, 6,653 (34% of all such visits) were by pts with at 
least 2 visits, including 5,977 (90%) which met the critaria for recidivism. These were aftdb- 
utable to 1,385 pts (9% of unique Lots), 892 with CAD and 493 with no evidence of CAD. 
There was a mean of 4,7 visits/pt for those with and 3.6 visits/pt for those without CAD. 
Recidivist pts without CAD were less likely than those with CAD to have HTN (60% vs 78%), 
diabetes (25% vs 39%), or dysiipidemia (29% vs 68%). For pts without CAD, those who had 
a nsgafive catheterization compared to those with a negative stress-imaging study or no 
diagnostic test performed on any given visit were less likely to be risk stratified at a higher 
level on the subsequent visit; 12% cath, vs 28% stress or 25% neither. These proportions 
were similar when comparing visit-2 to visit-1 or visit-3 to visit-2. Risk level was rarely 
changed at any presenation beyond visit-3. 
CONCLUSIONS: 10% of CP pts account for approximately 1/3 of all ED CP visits. This is 
frequently associated with risk stratification to a higher level on subsequent visits. Negative 
catheterization appears to have a greater influence on subsequent decision making in non- 
CAD pts than negative stress-imaging or having no diagnostic test performed. 
1143-165 Low Cost Tele-Echocardiography in an Urban/Suburban 
Environment 
Aoarna Kulkarni, M. Victoria Tantengco, Michael Pettersen, Tajinder P. Singh, Richard 
Humes, Children's Hospital of Michigan, Detroit, Michigan. 
Background: The utility of tele-echocardiography (TEL) is obvious as distances increase 
and access to specialty care decreases, particularly in rural areas. Yet, TEL comes at a 
cost of equipment and services. 
Objsctive: To compare the time and cost effectiveness of low-cost real time (384 Kbps, 
ISDN) TEL with on-site(ONS) echocardiography in an urban/suburban environment where 
travel distances are not great. 
Methods: "lJme activity data were collected over a period of 5 months from cardiologists at 
Children's Hospital of Michigen(CHM), traveling from CHM to other hospitals to review ech- 
oes ONS. Recordings Included travel time, time spent in the facility to review ONS and the 
total miles in travel. Similar measurements were obtained from cardiologists when they 
were reviewing echoes via TEL. Costs included telemedicine equipment ($8000), physician 
time ($60/hr), telephone line charges ($1200/site/yr) and mileage charges ($0.325/mi). 
Results: 138 Echoes were interpreted over 5 months of ONS echocardiography during the 
time study. 41.74 (+/-29,1)minutes were spent per echo, in addition to 22.5 (+/-10.7) min- 
utes of travel time with an average commute of 12.5 (+/-6.5) miles per echo. Thirty-six ech- 
oes were interpreted via TEL over a period of 3 weeks. Each echo required 14.77 (+/-4.3) 
rain. The physician time spent for ONS vs. TEL was significantly longer (p<0.000t). The 
cost of TEL equipment was compared to the cost of travelling for every ECHO performed. 
ONS interpretation of ECHO costs $65.10/ECHO, compared to $14.80/ECHO for TEL. 
Based on a 3-year amortization of fixed cost, costs for ONS exceed those for TEL when the 
transmitting site is more than 3.5 miles from the hub center. 
Conclusion: Low cost tsiemedicine provides a cost-effective alternative to physician travel 
and on site presence, even in e close urban setting. 
1143-166 Smoking Cessation and the Risk of Sudden Cardiac 
Death In Patients With Coronary Heart Disease 
lien Goldenbero, Michael Jonas, Alexander Tennenbaum, Valentine Boyco, Avraham 
Shotan, Solomon Behar, Henrietta Reicher-Reiss, Sheba Medical Center, Tel Hashomer, 
Israel 
Background: Cigarette smoking is a known risk factor for sudden cardiac death (SCD). 
However, the effect of smoking status on SCD risk in patients with established coronary 
heart disease (CHD) remains controversial. 
Methods: We prospectively studied 3122 patients with a previous myocardial infarction 
or stable angina over a mean follow-up period of 7 years - 370 patients were active 
smokers at randomization and throughout the study period; 1821 patients had quit smok- 
ing before or during the follow-up period; 931 patients had never smoked. The rate of 
SCD was determined according to smoking status. 
Results: In current smokers 30 sudden coronary deaths occurred (8.1%), whereas 83 
sudden coronary deaths occurred in patients who had quit smoking (4.6%) and 43 
patients who had never smoked died suddenly (4.6%, p=O.014). In multivariate analyses, 
current smoking was associated with a significant increase in the risk of SCD (relative 
risk- 2.47, 95%CI 1.46-4.19). Patients who had stopped smoking had no significant 
increase in the risk of SCD compared to patients who had never smoked (relative risk - 
1.06, 95%CI 0.70-1.61 Kaplan Meier survival curves comparing active smokers, past 
smokers and never smokers are shown the figure below. 
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Conclusion: In patients with CHD cigarette smoking elevates the risk of SOD, while 
smoking cessation results in a significant reduction in SCD rate. 
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1143-167 The Echo Stethoscope: Is It Ready for Prime Time by 
Medical Students? 
Lori B. Croft, Ben Cohen, Thomas Dorantes, Shilpa Hadsh, Matthew Stanizi, Eli Portnoy, 
Anthony Menasia, Eric H. Stem, Martin E. Goldman, Mr. Sinai Medical Center, New York, 
New York. 
Bsekeround: Hand-held inexpensive ultrasound systems have been developed but have 
only been utilized by skilled cardiologists or technologists. The maximum benefit of these 
"echo-stathoscopes" would be to empower all physicians with the skill to perform a "limited" 
bedside echo by incorporating echo into their physical exam as an echostethoscope; not to 
replace a formal echo. Methods: To determine the feasibility of a practical course to train 
medical students to perform echo, four first year medical students underwent a two week 
"hands-on" tutorial to perform and interpret a "limited" echo exam (defined as long, short 
and apical views, but no Doppler) to assess LV and size and function, and the presence of 
significant valvular disease or pericardial effusions. Results: The students acquired echo's 
in the emergency ward (119 pts) and intensive care unit (118 studies). The students' echo 
studies were overread and repeated by an echooardiologist who graded the student's tech- 
nical and interpretive skills. Of the 237 studies, 160 were done on the Cypress ® lap-top 
system (Acuson/Siemans) and 77 on the Sonosite ® hand-held system (Sonosite). The stu- 
dent's echo exam took 8.05 rain (_+ 3.5 mini. The students' limited echo was technically 
diagnostic in 96% and interpreted correctly in 80%. ~oncluelons: Thus, small echo sys- 
tems enable medical students to perform and accurately interpret limited studies following 
a brief training. Implications of this study support the feasibility of formally educating medi- 
cal students to utilize bedside echo-stethoscopes. 
1143-168 Cardiac Valve Calc i f icat ion Is an Important Predictor for  
Mortality in Renal Failure Patients on Dialysis 
Anaela Yee-Mson Wang, Mei WANG, Siu Fai LUI, John E. SANDERSON, Prince of 
Wales Hospital, Chinese University of Hong Kong, Hong Kong, Hong Kong. 
Background. Cardiac valve calcification (VC) is a frequent complication in dialysis patients. 
This study aims to determine the impact of VC on the outcome of these patients. 
Method. Echocardiography was performed in 191 peritoneal dialysis patients to determine 
the presence of calcification of the mitral, aortic valve or both, Patients were followed up 
prospectively for a median duration of 15.4 (range, 2.0-22.9) months. All-cause and cardio- 
vascular mortality were studied in relation to VC. 
Results. Mean age: 55 (12) yrs (M:F=97:94). Mean dialysis duration: 39 (31) months. 51 
patients (33%) had VC. Mean follow-up duration was 15 (4) vs 16 (4) months (VC vs non- 
VC). 40 endpoints (33 deaths and 7 transplants) were observed. 50% deaths were cardio- 
vascular causes. 28% (VC) vs 12% (non-VC) died among which 59% (VC) vs 38% (non- 
VC) group was from cardiovascular causes. Overall 1-year survival was 78% (VC) vs 92% 
(non-VC) (P=0.004). Mortality due to cardiovascular causes was 15% (VC) vs 4% (non- 
VC) (P=0.004; log rank test). VC patients had higher all-cause [Hazard ratio (HR) = 2.62, 
(95% CI: 1.32-5.19); P=0.006] and cardiovascular mortality [HR = 5.71, (95% CI: 2.12- 
15.37); P=0.001] than non-VC patients. Using stepwise Cox regression analysis, VC 
remained significantly & independently associated with an increased all-cause and cardio- 
vascular mortality after adjusting for demographic (age, sex, dialysis duration, diabetes, 
smoking), biochemical (CRP, albumin, calcium x phosphate, parathyroid hormone, choles- 
terol), blood pressure and atherosclerotic diseases (AVD). Presence of both aortic and 
mitral VC had a HR of 5.72 (95% CI: 1.43-22.90) (P=0.014) while those with either mitral or 
aortic VC had a HR of 3.54 (95% CI: 1.19-10.54) (P=0.023) for all-cause mortality than 
those with no VC, Moreover, all-cause and cardiovascular mortality were significantly 
higher among patients with both VC and AVD compared to those having either VC or AVD 
and were in turn higher than those with neither VC nor AVD. 
Conclusions. VC is a powerful predictor for mortality and cardiovascular deaths in dialysis 
patients. Its co-existence with clinical AVD represents more severe atherosclerofic dis- 
eases and predicts a worse outcome. 
1143-169 Cost Comparison of Radiofrequency Ablation and 
Antiarrhythmic Therapy of Atr ia l  F lutter 
Brahmaiee Nallamothu, Frank Pelosi, Jr., Bradley P. Knight, S. Adam Strickberger, Fred 
Morady, Hakan Oral, Universi~ of Michigan, Ann Arbor, Michigan. 
Purpose: Radiofrequency ablation (RFA) is very effective in treatment of atrial flutter (AFI). 
However, RFA is associated with procedural costs and low-incidence of potential complica- 
tions. The purpose of this study was to compare the cost of RFA and antiarrhythmic (AA) 
therapy in patients with AFI. 
Methods: Using a Marker model, the clinical benefits and costs of 2 treatment strategies, 
RFA and chronic AA therapy with a class IC agent, propafenone, were compared in a 
hypothetical cohort of men and women at a mean age of 50. The base-case estimates and 
costs were derived from the literature and 60 consecutive patients who underwent RFA at 
the University of Michigan (mean age= 58 -+ 13). Major assumptions of the model were: 1) 
an annual AFI event rate of 4 episodes per year; 2) a 60% risk reduction with propafenone; 
3) a 10% annual discontinuation rate for prepafenone; 4) an annual pro-arrhythrnia rate of 
0.025% with propafenone; 5) a 90% RFA-success rate for PAF; 6) an RFA-complication 
rate of 1% and a mortality rate of 0.1%; and 7) a 10% annual AFI recurrence rate after RFA, 
Results: Compared to chronic AA, RFA was the dominant strategy in patients with AR, 
reducing lifetime arrhythmia-assooiated costs by $41,000. This result was robust to a wide 
range of potential values for several key model inputs including the frequency of AFI events 
and the efficacy, complication rates, and costs of AA therapy and RFA. For instance, RFA 
remained more effective and less expensive than chronic AA therapy during a sensitivity 
analysis where we assumed that RFA efficacy was lowered to 75%, its complication and 
mortality rates were increased to 3% and 0.3%, respectively, and its costs were doubled. 
Conclusions: RFA for AFI in patients without structural heart disease is associated with a 
substantial decrease in lifetime arrhythmia-associated costs when compared to AA ther- 
apy. 
